CVR number 13902372
Industry 86.9020 Other human health activities

KLINIK FOR FYSIOTERAPI V/BJARKE BILDE ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  2.2% 2.8% 1.9% 6.2% 2.8%  
Credit score (0-100)  67 58 68 37 59  
Credit rating  BBB BBB A BBB BBB  
Credit limit (kDKK)  0.1 0.0 0.6 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  2,649 3,222 2,810 6,036 2,421  
EBITDA  768 1,256 807 4,139 563  
EBIT  738 1,230 781 4,112 541  
Pre-tax profit (PTP)  738.1 1,217.5 772.5 4,110.8 541.4  
Net earnings  575.2 948.0 601.2 3,205.9 422.2  
Pre-tax profit without non-rec. items  738 1,218 773 4,111 541  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  136 110 82.9 56.2 34.4  
Shareholders equity total  1,492 1,940 1,541 4,147 1,369  
Interest-bearing liabilities  287 0.0 93.2 59.7 0.0  
Balance sheet total (assets)  2,148 2,545 1,962 5,265 1,610  
Net Debt  -879 -1,157 -1,111 -4,774 -1,223  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,649 3,222 2,810 6,036 2,421  
Gross profit growth  -7.6% 21.7% -12.8% 114.8% -59.9%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,148 2,545 1,962 5,265 1,610  
Balance sheet change%  29.9% 18.5% -22.9% 168.3% -69.4%  
Added value  768.3 1,256.2 807.3 4,138.9 563.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  24 -53 -53 -53 -44  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  27.9% 38.2% 27.8% 68.1% 22.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  38.8% 52.4% 34.6% 113.8% 15.7%  
ROI %  48.5% 66.1% 43.6% 140.7% 19.4%  
ROE %  44.1% 55.2% 34.5% 112.7% 15.3%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  69.5% 76.2% 78.6% 78.8% 85.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -114.4% -92.1% -137.6% -115.3% -217.1%  
Gearing %  19.2% 0.0% 6.0% 1.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 8.4% 17.5% 1.8% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  3.3 7.3 7.6 24.8 13.1  
Current Ratio  3.3 7.3 7.6 24.8 13.1  
Cash and cash equivalent  1,166.0 1,156.8 1,204.3 4,833.4 1,223.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,400.6 2,101.4 1,632.4 4,998.1 1,456.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 282  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 282  
EBIT / employee  0 0 0 0 271  
Net earnings / employee  0 0 0 0 211